AKTX 8-K 2026-10-01

Akari Therapeutics Plc (AKTX) 8-K dated 2026-10-01 — accession 0001493152-26-045364. This URL is the filing, not the AKTX hub.

Akari Therapeutics Plc (AKTX) is a biotechnology company listed on US.

Akari Therapeutics Plc filed a 8-K on 2026-10-01. Accession 0001493152-26-045364.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AKTX revenue for 2024-06-30 was $0. Net income was -$7.6M. AKTX currently screens at market cap $17.2M.

Not investment advice. The AKTX SEC hub lists recent forms. The stock page is the research view.